FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

10470311000001107: Pyridostigmine bromide 180mg modified-release tablets 100 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Oct 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
35970701000001116 Pyridostigmine bromide 180mg modified-release tablets 100 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
35970801000001113 Pyridostigmine bromide 180mg modified-release tablets 100 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Pyridostigmine bromide 180mg modified-release tablets 100 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Pyridostigmine bromide 180mg modified-release tablets 100 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Pyridostigmine bromide 180mg modified-release tablets 100 tablet Is pack of Pyridostigmine bromide 180mg m/r tablet false Inferred relationship Existential restriction modifier
Pyridostigmine bromide 180mg modified-release tablets 100 tablet Has active ingredient Pyridostigmine bromide false Inferred relationship Existential restriction modifier
Pyridostigmine bromide 180mg modified-release tablets 100 tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Pyridostigmine bromide 180mg modified-release tablets 100 tablet VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Pyridostigmine bromide 180mg modified-release tablets 100 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Pyridostigmine bromide 180mg modified-release tablets 100 tablet VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Pyridostigmine bromide 180mg modified-release tablets 100 tablet Has VMP Pyridostigmine bromide 180mg m/r tablet false Inferred relationship Existential restriction modifier
Pyridostigmine bromide 180mg modified-release tablets 100 tablet Has specific active ingredient Pyridostigmine bromide true Inferred relationship Existential restriction modifier
Pyridostigmine bromide 180mg modified-release tablets 100 tablet Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Pyridostigmine bromide 180mg modified-release tablets 100 tablet Has VMP Pyridostigmine bromide 180mg modified-release tablets false Inferred relationship Existential restriction modifier
Pyridostigmine bromide 180mg modified-release tablets 100 tablet Has VMP Pyridostigmine bromide 180mg modified-release tablets true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Mestinon retard 180mg tablets (Viatris UK Healthcare Ltd) 100 tablet Is a True Pyridostigmine bromide 180mg modified-release tablets 100 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start